Hybrid Closed-Loop Therapy Raises Time in Range 10 Points in Preschoolers
Analysis Endocrinology / Diabetes / Obesity Confirmatory Grade: Moderate
Zhang T, Wang N, Wang B, et al.
Sep 30, 2026 · Published in: Pediatric Diabetes
Also in Pediatrics
Hybrid closed-loop systems enhance pediatric diabetes control safely.
Bihormonal Fully Closed-Loop System Raises Adolescent Time in Range by 13.6 Points
Analysis Pediatrics Hypothesis-generating Grade: Low
Booijink RS, de Haan JS, Van Den Berg L, et al.
Sep 30, 2026 · Published in: Pediatric Diabetes
Also in Endocrinology / Diabetes / Obesity
Bihormonal closed-loop system boosts glucose control in teens with Type 1 diabetes.
Pharmacist-Embedded Liver Fibrosis Screening Finds Hidden Cirrhosis in Diabetes
Analysis Clinical Practice Hypothesis-generating Grade: Low
Wexler RP, Chimene-Weiss J, Cameron C, et al.
Sep 29, 2026 · Published in: Journal of Managed Care & Specialty Pharmacy
Also in Ambulatory Care / MTM, Endocrinology / Diabetes / Obesity
Pharmacists enhance liver disease detection in diabetes care.
Racial Gaps in Diabetes Adherence Persist Within Medicare Advantage Plans
★ Editor's Pick Analysis Ambulatory Care / MTM Confirmatory Grade: Moderate
Essien UR, Roberts ET, Ruggiero DA, et al.
Sep 28, 2026 · Published in: JAMA Network Open
Also in Endocrinology / Diabetes / Obesity
Medication adherence in diabetes shows racial and ethnic disparities.
Automated Insulin Delivery Improves Glycemia, Not Yet Perinatal Outcomes
★ Editor's Pick Analysis Women's Health / Reproductive Confirmatory Grade: Moderate
Li J, Qi TN, Tan X, et al.
Sep 23, 2026 · Published in: Journal of Diabetes Research
Also in Endocrinology / Diabetes / Obesity
Automated insulin delivery transforms diabetes management in pregnancy.
Indirect Network Meta-Analysis Ranks Cardiorenal Drugs in Diabetic CKD
Analysis Endocrinology / Diabetes / Obesity Confirmatory Grade: Low
Chen H, Wu X, Yuan M, et al.
Sep 23, 2026 · Published in: Frontiers in Endocrinology
Also in Nephrology, Cardiology
SGLT2 inhibitors show promise for renal outcomes in T2D-CKD.
SGLT2 versus DPP-4 Inhibitors: Modest Glycemic Edge, Consistent Weight Benefit
Analysis Endocrinology / Diabetes / Obesity Confirmatory Grade: Moderate
Fang X, Li R, Liu S, et al.
Sep 19, 2026 · Published in: Frontiers in Endocrinology
SGLT2 inhibitors excel in control but risk infections.
GLP-1 and SGLT-2 Therapies for Diabetes Prevention After Gestational Diabetes
Analysis Women's Health / Reproductive Hypothesis-generating Grade: Low
Vanlaer Y, Van de Cauter E, Embo N, et al.
Sep 10, 2026 · Published in: BMC Medicine
Also in Endocrinology / Diabetes / Obesity
Emerging therapies may prevent diabetes post-gestational diabetes.
Incretin Agonists as Rescue Therapy After Bariatric Surgery
Analysis Endocrinology / Diabetes / Obesity Confirmatory Grade: Low
Santos-Pereira M, Frutuoso JF, Pereira SS, et al.
Sep 10, 2026 · Published in: Frontiers in Endocrinology
Incretin receptor agonists enhance weight loss post-bariatric surgery.
Levothyroxine linked to short-term creatinine improvement in hypothyroid inpatients
Analysis Endocrinology / Diabetes / Obesity Hypothesis-generating Grade: Very Low
Zhao T, Zhang N, Tian Y, et al.
Sep 8, 2026 · Published in: Frontiers in Endocrinology
Also in Nephrology
Thyroid hormone therapy reverses renal dysfunction in hypothyroidism.
Outcome-Stratified Positioning of Incretin Therapies Across Cardiometabolic Phenotypes
Analysis Endocrinology / Diabetes / Obesity Confirmatory Grade: Low
Sztanek F, Lőrincz H, Harangi M, et al.
Sep 2, 2026 · Published in: Diabetes, Obesity & Metabolism
Also in Nephrology
Incretin therapies expand treatment options for cardiometabolic conditions.
Once-Weekly Efsitora Hypoglycemia Duration Matches Daily Basal Insulins
Analysis Endocrinology / Diabetes / Obesity Confirmatory Grade: Low
Bellini N, Bergenstal RM, Giménez M, et al.
Sep 1, 2026 · Published in: Diabetes Research and Clinical Practice
Is once-weekly insulin as safe as daily doses for hypoglycemia?
Omnipod 5 sustains glycemic gains over 12 months in adults
Analysis Endocrinology / Diabetes / Obesity Confirmatory Grade: Low
Renard E, Weinstock RS, Penfornis A, et al.
Aug 31, 2026 · Published in: Endocrinology, Diabetes & Metabolism
The Omnipod 5 System enhances and sustains diabetes control long-term.
Pharmacist-Led Framework for Perioperative GLP-1 Agonist Risk Management
Analysis Perioperative / Anesthesia Hypothesis-generating Grade: Low
Shen N, Zhu C, Wang F, et al.
Aug 29, 2026 · Published in: Therapeutics and Clinical Risk Management
Also in Endocrinology / Diabetes / Obesity
Pharmacists can lead the safe perioperative management of GLP-1 receptor agonists.
Incretin Therapies Reshape Post-Bariatric Weight Recurrence Management
Analysis Endocrinology / Diabetes / Obesity Confirmatory Grade: Low
Huerta Díaz LA, Lopez Alanis BA, Zorrilla-Nuñez LF, et al.
Aug 28, 2026 · Published in: Cureus
Incretin-based therapies redefine post-bariatric weight management.